Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Volume 13 - Issue 2 - February 2016

An International Trial of Carotid Surgery Compared to Stenting: Interview With Jonathan D. Beard, MD
01/26/2016
Jonathan D. Beard, MD, was a co-applicant, participating physician and member of the Steering Committee of the International Carotid Stenting Study (ICSS). At the 2015 VEITH Symposium in New York, Vascular Disease Management spoke with Dr....
Jonathan D. Beard, MD, was a co-applicant, participating physician and member of the Steering Committee of the International Carotid Stenting Study (ICSS). At the 2015 VEITH Symposium in New York, Vascular Disease Management spoke with Dr....
Jonathan D. Beard, MD, was a...
01/26/2016
Vascular Disease Management
An International Trial of Carotid Surgery Compared to Stenting: Interview With Jonathan D. Beard, MD
01/26/2016
Jonathan D. Beard, MD, was a co-applicant, participating physician and member of the Steering Committee of the International Carotid Stenting Study (ICSS). At the 2015 VEITH Symposium in New York, Vascular Disease Management spoke with Dr....
Jonathan D. Beard, MD, was a co-applicant, participating physician and member of the Steering Committee of the International Carotid Stenting Study (ICSS). At the 2015 VEITH Symposium in New York, Vascular Disease Management spoke with Dr....
Jonathan D. Beard, MD, was a...
01/26/2016
Vascular Disease Management
Anthony Comerota, MD, Describes Vorapaxar for Peripheral Arterial Disease
01/26/2016
Anthony Comerota, MD, a participant in the TRA 2°P study of vorapaxar for patients with peripheral arterial disease, speaks with Vascular Disease Management about data on effectiveness of vorapaxar for patients with peripheral arterial...
Anthony Comerota, MD, a participant in the TRA 2°P study of vorapaxar for patients with peripheral arterial disease, speaks with Vascular Disease Management about data on effectiveness of vorapaxar for patients with peripheral arterial...
Anthony Comerota, MD, a...
01/26/2016
Vascular Disease Management
Anthony Comerota, MD, Describes Vorapaxar for Peripheral Arterial Disease
01/26/2016
Anthony Comerota, MD, a participant in the TRA 2°P study of vorapaxar for patients with peripheral arterial disease, speaks with Vascular Disease Management about data on effectiveness of vorapaxar for patients with peripheral arterial...
Anthony Comerota, MD, a participant in the TRA 2°P study of vorapaxar for patients with peripheral arterial disease, speaks with Vascular Disease Management about data on effectiveness of vorapaxar for patients with peripheral arterial...
Anthony Comerota, MD, a...
01/26/2016
Vascular Disease Management
Rapid Lysis Technique for Deep Vein Thrombosis: Interview With Mark J. Garcia, MD
01/26/2016
Vascular Disease Management spoke with Dr. Garcia at the 2015 VEITH Symposium about a technique he developed using a thrombectomy system for acute and subacute deep vein thrombosis.
Vascular Disease Management spoke with Dr. Garcia at the 2015 VEITH Symposium about a technique he developed using a thrombectomy system for acute and subacute deep vein thrombosis.
Vascular Disease Management...
01/26/2016
Vascular Disease Management
Rapid Lysis Technique for Deep Vein Thrombosis: Interview With Mark J. Garcia, MD
01/26/2016
Vascular Disease Management spoke with Dr. Garcia at the 2015 VEITH Symposium about a technique he developed using a thrombectomy system for acute and subacute deep vein thrombosis.
Vascular Disease Management spoke with Dr. Garcia at the 2015 VEITH Symposium about a technique he developed using a thrombectomy system for acute and subacute deep vein thrombosis.
Vascular Disease Management...
01/26/2016
Vascular Disease Management
Percutaneous Transcatheter Closure of a Large Pseudoaneurysm Arising From Anastomosis of a Surgical Graft With an Amplatzer Vascular Plug 4
01/26/2016

Mark J. Russo, MD1; Ross Milner, MD2; Atman P. Shah, MD2

 

1Barnabas Heart Health Centers, Newark, New Jersey; 2University of Chicago Medicine, Chicago, Illinois

Mark J. Russo, MD1; Ross Milner, MD2;...
The authors report a case of closure of an aortic pseudoaneurysm with a novel occluder, the Amplatzer Vascular Plug 4 (St. Jude Medical).
The authors report a case of closure of an aortic pseudoaneurysm with a novel occluder, the Amplatzer Vascular Plug 4 (St. Jude Medical).
The authors report a case of...
01/26/2016
Vascular Disease Management
Impact of Family History on Reintervention Rate During Follow-up After Aneurysm Repair
01/26/2016

Roy Miler, MD1; Christopher R. Marcellino, MD2; Rocio T. Moran, MD3; Matthew J. Eagleton, MD1; Chase R. Brown, MD1; James Bena, MD1; Tara M. Mastracci, MD4

 

1Cleveland Clinic, Cleveland, Ohio; 2Case Western Reserve University, Cleveland, Ohio; 3MetroHealth Medical Center, Cleveland, Ohio; 4Royal Free London NHS Foundation Trust, London, United Kingdom.

Roy Miler, MD1; Christopher R. Marcel...
The authors aim to determine whether, in a group of patients with an established familial pattern of aortic disease, there is a risk of development of new aneurysm in the follow-up period, and whether this risk differs from that of patients...
The authors aim to determine whether, in a group of patients with an established familial pattern of aortic disease, there is a risk of development of new aneurysm in the follow-up period, and whether this risk differs from that of patients...
The authors aim to determine...
01/26/2016
Vascular Disease Management
Impact of Family History on Reintervention Rate During Follow-up After Aneurysm Repair
01/26/2016
The authors aim to determine whether, in a group of patients with an established familial pattern of aortic disease, there is a risk of development of new aneurysm in the follow-up period, and whether this risk differs from that of patients...
The authors aim to determine whether, in a group of patients with an established familial pattern of aortic disease, there is a risk of development of new aneurysm in the follow-up period, and whether this risk differs from that of patients...
The authors aim to determine...
01/26/2016
Vascular Disease Management

Feature

Case Report
Percutaneous Transcatheter Closure of a Large Pseudoaneurysm Arising From Anastomosis of a Surgical Graft With an Amplatzer Vascular Plug 4
01/26/2016
The authors report a case of closure of an aortic pseudoaneurysm with a novel occluder, the Amplatzer Vascular Plug 4 (St. Jude Medical).
The authors report a case of closure of an aortic pseudoaneurysm with a novel occluder, the Amplatzer Vascular Plug 4 (St. Jude Medical).
The authors report a case of...
01/26/2016
Vascular Disease Management

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

Sleep and CVD
Study of Sleep in Women Shows Delaying Bedtime by Just 90 Minutes Each Night Damages Endothelial Cells
08/06/2024
After just six weeks of shortened sleep, the study found, the cells that line our blood vessels are flooded by damaging oxidants. And unlike well-rested cells, sleep-restricted cells fail to activate antioxidant responses to clear the...
After just six weeks of shortened sleep, the study found, the cells that line our blood vessels are flooded by damaging oxidants. And unlike well-rested cells, sleep-restricted cells fail to activate antioxidant responses to clear the...
After just six weeks of...
08/06/2024
Cath Lab Digest
Peripheral Interventions
VentureMed Completes Enrollment of the FLEX Vessel Prep System FLEX First AV Registry For The Treatment of Arteriovenous (AV) Access Management
07/30/2024
The FLEX Vessel Prep System has a unique non-balloon-based mechanism of action that creates longitudinal micro-incisions that release circumferential tension in diseased vessels. This release of tension is how FLEX modifies AV stenoses to...
The FLEX Vessel Prep System has a unique non-balloon-based mechanism of action that creates longitudinal micro-incisions that release circumferential tension in diseased vessels. This release of tension is how FLEX modifies AV stenoses to...
The FLEX Vessel Prep System has...
07/30/2024
Cath Lab Digest
Peripheral Interventions
Transit Scientific’s Novel XO Cath Microcatheter Breaks New Ground in Transradial Embolic Delivery Procedure
07/30/2024
​ Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, announced a milestone achievement with the successful utilization of XO Cath, its pioneering embolic delivery...
​ Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, announced a milestone achievement with the successful utilization of XO Cath, its pioneering embolic delivery...
​ Transit Scientific, a...
07/30/2024
Cath Lab Digest
Carotid Artery Revascularization
Silk Road Medical Celebrates Milestone of 100,000 Transcarotid Artery Revascularization (TCAR) Procedures
07/30/2024
Transcarotid Artery Revascularization (TCAR) is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a...
Transcarotid Artery Revascularization (TCAR) is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a...
Transcarotid Artery...
07/30/2024
Cath Lab Digest
Health Care Needs
JACC: Almost Half of U.S. Counties Have No Cardiologists Despite Higher Prevalence of CV Risk Factors, Mortality
07/29/2024
Upon analyzing all 3,143 U.S. counties, it was determined that 1,454 counties (46.3%) with 22 million residents had no cardiologists while the other 1,689 counties each had 24 cardiologists on average. 86.2% of rural counties had no...
Upon analyzing all 3,143 U.S. counties, it was determined that 1,454 counties (46.3%) with 22 million residents had no cardiologists while the other 1,689 counties each had 24 cardiologists on average. 86.2% of rural counties had no...
Upon analyzing all 3,143 U.S....
07/29/2024
Cath Lab Digest
Renal Denervation
First Patients Treated in Recor Medical’s Global Paradise System US Post Approval Study (US GPS) for the Treatment of Uncontrolled Hypertension With Ultrasound Renal Denervation
07/25/2024
The study will focus on gathering real-world safety and effectiveness data over five years from up to 1,000 patients, collaborating with research centers to help advance diversity and health equity within clinical trials. Building upon the...
The study will focus on gathering real-world safety and effectiveness data over five years from up to 1,000 patients, collaborating with research centers to help advance diversity and health equity within clinical trials. Building upon the...
The study will focus on...
07/25/2024
Cath Lab Digest
Ischemic Stroke
Imperative Care Announces Clinical Data from the Pivotal Imperative Trial Evaluating the Zoom Reperfusion System for the Treatment of Ischemic Stroke
07/24/2024
“The observed data showed all three pre-specified performance goals were met. These data suggest a lower rate of rescue therapy than prior thrombectomy trials and may demonstrate that intracranial positioning of a super-large bore catheter...
“The observed data showed all three pre-specified performance goals were met. These data suggest a lower rate of rescue therapy than prior thrombectomy trials and may demonstrate that intracranial positioning of a super-large bore catheter...
“The observed data showed all...
07/24/2024
Cath Lab Digest
LINC
News
HMP Global’s Leipzig Interventional Course (LINC) Announces 20th Anniversary Congress in January 2025
07/22/2024
LINC, the world’s premier interdisciplinary live course for vascular and endovascular teams, announced that its annual meeting is shifting from summer to winter, with its 20th anniversary Congress in January 2025.
LINC, the world’s premier interdisciplinary live course for vascular and endovascular teams, announced that its annual meeting is shifting from summer to winter, with its 20th anniversary Congress in January 2025.
LINC, the world’s premier...
07/22/2024
Vascular Disease Management
News
Life Seal Vascular Inc. Awarded Prestigious NSF SBIR Grant to Advance Innovative Endovascular Aortic Aneurysm Sac Management Technology
07/17/2024
More than $274,000 in NSF funding to develop breakthrough aneurysm sac management technology
More than $274,000 in NSF funding to develop breakthrough aneurysm sac management technology
More than $274,000 in NSF...
07/17/2024
Vascular Disease Management
Ischemic Stroke
Imperative Care Announces FDA Clearance and Initial Cases of the Zoom 6F Insert Catheters, the First Insert Catheters Built for Stroke
07/17/2024
Based on physician feedback, the new Zoom 6F Insert Catheters were developed to be more supportive, more torque-able and longer than current vessel selection devices and are offered in three stroke-specific shapes.
Based on physician feedback, the new Zoom 6F Insert Catheters were developed to be more supportive, more torque-able and longer than current vessel selection devices and are offered in three stroke-specific shapes.
Based on physician feedback, the...
07/17/2024
Cath Lab Digest

Advertisement

Advertisement

February 2016 Volume 13 Issue 2

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement